EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
40 hedge funds and large institutions have $101M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
40
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.43M | |
| 2 | +$5.36M | |
| 3 | +$4.18M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$2.58M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.09M |
Top Sellers
| 1 | -$1.52M | |
| 2 | -$1.12M | |
| 3 | -$607K | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$341K |
| 5 |
Millennium Management
New York
|
-$178K |